What they were paid
SUTRO BIOPHARMA Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $53,500 | $0 | $41,795 | $0 | $95,295 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SUTRO BIOPHARMA, INC. DEF 14A filed April 22, 2026, accession 0001193125-26-170354, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025SUTRO BIOPHARMA pays directors a $40,000 cash retainer and $41,795 in equity.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance
The rest of the SUTRO BIOPHARMA board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Connie Matsui | Independent Director | $121,795 |
| Heidi Hunter | Independent Director | $99,295 |
| James Panek | Independent Director | $96,795 |
| Jane Chung, R.Ph | Director | $0 |
| Jon Wigginton, M.D | Independent Director | $100,295 |
| Joseph M. Lobacki | Independent Director | $108,795 |
| Michael Dybbs, Ph.D | Independent Director | $86,795 |
| Sukhi Jagpal | Independent Director | $99,295 |
The full SUTRO BIOPHARMA compensation record
free company briefThis page is one director within SUTRO BIOPHARMA's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat